A share price of ClearPoint Neuro Inc [CLPT] is currently trading at $11.68, down -2.01%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CLPT shares have gain 6.96% over the last week, with a monthly amount glided 3.09%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Stifel started tracking the stock with Buy rating on October 24, 2023, and set its price target to $8. Lake Street initiated its recommendation with a Buy and recommended $32 as its price target on March 18, 2021. B. Riley FBR started tracking with a Buy rating for this stock on July 17, 2020, and assigned it a price target of $8.
ClearPoint Neuro Inc experienced fluctuations in its stock price throughout the past year between $9.40 and $19.22. Currently, Wall Street analysts expect the stock to reach $18 within the next 12 months. ClearPoint Neuro Inc [NASDAQ: CLPT] shares were valued at $11.68 at the most recent close of the market. An investor can expect a potential return of 54.11% based on the average CLPT price forecast.
Analyzing the CLPT fundamentals
Trailing Twelve Months sales for ClearPoint Neuro Inc [NASDAQ:CLPT] were 33.59M which represents 17.27% growth. Gross Profit Margin for this corporation currently stands at 0.6% with Operating Profit Margin at -0.67%, Pretax Profit Margin comes in at -0.66%, and Net Profit Margin reading is -0.66%. To continue investigating profitability, this company’s Return on Assets is posted at -0.35, Equity is -0.94 and Total Capital is -0.41. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.33.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 11.30 points at the first support level, and at 10.91 for the second support level. However, for the 1st resistance point, the stock is sitting at 11.99, and for the 2nd resistance point, it is at 12.29.
Ratios To Look Out For
To put it in perspective, the Current Ratio for ClearPoint Neuro Inc [NASDAQ:CLPT] is 7.30. In addition, the Quick Ratio stands at 6.45 and the Cash Ratio stands at 5.62. Considering the valuation of this stock, the price to sales ratio is 9.83, the price to book ratio is 16.82.
Transactions by insiders
Recent insider trading involved Richards Timothy T., Director, that happened on Jun 10 ’25 when 10000.0 shares were sold. CEO and President, BURNETT JOSEPH completed a deal on Jun 09 ’25 to sell 21247.0 shares. Meanwhile, Director TIMOTHY RICHARDS bought 10000.0 shares on Jun 10 ’25.
